Hospital
Adventist Healthcare, INC.
Adventist Healthcare, INC. was paid $4.50M by Medicaid between Jan 2018 and Dec 2024, across 103 billing codes. Its largest line is 99284, emergency room visit (serious) — 26% of everything it billed.
33Billing provider infoADVENTIST HEALTHCARE, INC.
SILVER SPRING, MD 20904
SILVER SPRING, MD 20904
33aNPI1487650024assigned 06/27/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.50M
24GClaims136,388
24DCodes billed103
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Maryland
Rank by total paid#9 of 69
Median peer was paid$870K
This provider vs. median5.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LEE, JAMES controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,308 | $1.14M | |
| 2019 | 33,594 | $1.30M | |
| 2020 | 17,241 | $599K | |
| 2021 | 17,750 | $509K | |
| 2022 | 15,464 | $436K | |
| 2023 | 12,521 | $344K | |
| 2024incomplete | 7,510 | $178K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 5,944 | 5,172 | $1.16M |
| G0378 | Hospital observation service, per hour | 25% | 1,940 | 1,467 | $1.12M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 7,229 | 6,138 | $893K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.4% | 2,031 | 1,808 | $332K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.4% | 8,501 | 7,205 | $110K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.9% | 518 | 406 | $85K |
| 84484 | 1.8% | 7,893 | 4,790 | $82K | |
| 80053 | Comprehensive metabolic panel | 1.6% | 9,626 | 7,603 | $71K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 15,319 | 11,163 | $63K |
| 71045 | Radiologic examination, chest; single view | 1.1% | 4,308 | 3,796 | $52K |
| 87040 | <1% | 443 | 383 | $44K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 480 | 414 | $34K |
91 more codes
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 478 | $26K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 331 | $25K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,600 | $25K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 416 | $24K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,084 | $24K |
| 87070 | <1% | 429 | $23K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,443 | $23K |
| 84702 | <1% | 714 | $20K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 816 | $19K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 863 | $18K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 796 | $17K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 327 | $16K |
| 82962 | <1% | 4,712 | $14K | |
| 83690 | <1% | 3,231 | $12K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,047 | $12K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 268 | $11K |
| 87486 | <1% | 347 | $11K | |
| 87581 | <1% | 331 | $11K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 72 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 246 | $8K |
| 82553 | <1% | 1,376 | $8K | |
| 81001 | <1% | 2,672 | $7K | |
| 93971 | <1% | 44 | $7K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 198 | $7K |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 375 | $7K |
| 93307 | <1% | 121 | $7K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 156 | $5K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 58 | $5K |
| 93458 | <1% | 125 | $4K | |
| 83880 | <1% | 533 | $4K | |
| 82550 | <1% | 1,580 | $4K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 15 | $4K |
| 81003 | <1% | 1,713 | $3K | |
| 87210 | <1% | 40 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,701 | $3K |
| 83605 | <1% | 310 | $3K | |
| 85610 | <1% | 2,940 | $3K | |
| 83735 | <1% | 1,956 | $3K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 357 | $2K |
| 86850 | <1% | 2,037 | $2K | |
| 85730 | <1% | 2,193 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 180 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 886 | $2K |
| 87088 | <1% | 292 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 317 | $1K |
| 86900 | <1% | 2,314 | $1K | |
| 85378 | <1% | 101 | $1K | |
| 80061 | Lipid panel | <1% | 310 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 265 | $1K |
| 97161 | <1% | 13 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,492 | $1K |
| 86901 | <1% | 2,064 | $1K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 27 | $1K |
| 94760 | <1% | 344 | $985.55 | |
| C1769 | Guide wire | <1% | 664 | $880.46 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 680 | $735.58 |
| 82077 | <1% | 37 | $711.02 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 2,403 | $675.81 |
| 94664 | <1% | 145 | $672.11 | |
| 0223U | <1% | 54 | $639.00 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 60 | $482.33 |
| 87400 | <1% | 21 | $457.74 | |
| 81015 | <1% | 178 | $445.40 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 285 | $431.84 |
| 85027 | <1% | 192 | $357.40 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 184 | $353.47 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 560 | $241.90 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 16 | $226.83 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,876 | $211.16 |
| 87641 | <1% | 12 | $194.24 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 136 | $176.75 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 250 | $167.45 |
| 84100 | <1% | 198 | $161.12 | |
| J2704 | Injection, propofol, 10 mg | <1% | 906 | $140.14 |
| 87186 | <1% | 27 | $87.21 | |
| 80076 | <1% | 13 | $83.08 | |
| 84439 | <1% | 12 | $79.73 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,154 | $67.80 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 132 | $29.84 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 44 | $16.43 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 110 | $10.99 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 17 | $0.12 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 53 | $0.10 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 39 | $0.05 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 690 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 240 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 19 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 15 | $0.00 |
| 84132 | 0% | 13 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 43 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEE, JAMES (EVP/CFO)
| Provider | Location | Paid |
|---|---|---|
| Kona Hospital | Kealakekua, HI | $22.27M |
| Adventist Healthcare, INC. | Rockville, MD | $9.70M |
| Adventist Healthcare Urgent Care Centers INC | Rockville, MD | $1.56M |
| Pure Dental, PC | Flushing, NY | $1.24M |
| Access Home Medical LLC | Sumter, SC | $520K |
| Adventist Rehabilitation Hospital of Maryland INC | Rockville, MD | $470K |
| James Lee MD PC | Colorado Springs, CO | $450K |
| Peak Surgery Center LLC | Colorado Springs, CO | $36K |
| Ascension Behavioral Healthcare, P.A. | Rock Hill, SC | $23K |
| Heartcare, PC | Cullman, AL | $8K |
| DR Keith Lee-Integrative Mental Health, LLC | Owensboro, KY | $6K |
| Ent & Allergy Specialists of Virginia PC | Ashburn, VA | $1K |
| Outpatient Biopsy Center | Alhambra, CA | $430.63 |
| Adventist Healthcare, INC. | Rockville, MD | $0.00 |
| Vascular Center of Intervention, INC. | Fresno, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.